Norway, Feb. 3 -- Medistim ASA, a leading niche provider of ultrasound technology headquartered in Oslo, Norway, today announced the establishment of a direct sales operation in Japan, effective March 16, 2026. Medistim develops and commercializes advanced medical equipment for use in cardiac, vascular, and transplant surgery. The expansion into a direct sales model in Japan is intended to strengthen the company's market presence and enhance customer engagement in one of its key strategic markets. This initiative underscores Medistim's continued commitment to delivering high-quality service and clinical support to cardiovascular surgeons globally and aligns with the Company's long-term global growth strategy.Medistim maintains a very strong...